John M. Slopis - Concepedia

Author

John M. Slopis

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

J Slopis, J. M. Slopis, J.M. Slopis, JOHN M. SLOPIS, Jamie K. Capal, John M Slopis, John M. Slopis, John Mark Slopis, John Slopis

106

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston Cancer Genetics (United States)Texas Medical Center The University of Texas at Austin

About

John M. Slopis is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.4K
2	Health Sciences	4	4	245
3	Social Sciences	3	3	231
4	Engineering	1	1	14
5	Language Studies	1	1	46

John M. Slopis

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome Changye Zou, Kerrington D. Smith, Guy Lahat, Annals of Surgery	2009	319
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas Arkadiusz Piotrowski, Jing Xie, Ying F Liu, Nature Genetics Developmental AnomalyRare DiseasesSomatic VariantMendelian DisorderGenetic Disorder	2013	315
The molecular landscape of glioma in patients with Neurofibromatosis 1 Fulvio D’Angelo, Michele Ceccarelli, Tala, Nature Medicine Neuro-oncologyTumor HeterogeneityNeurofibromatosis 1PathologyBrain Tumor Biology	2018	203
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020 Jace P. Landry, Kelsey Schertz, Yi‐Ju Chiang, JAMA Network Open	2021	159
Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis Bartlett D. Moore, John M. Slopis, Donald L. Schomer, Neurology NeuropsychologyNeuropsychological SignificanceBasal GangliaNeuropsychiatryBrain Lesion	1996	149
Brain volume in children with neurofibromatosis type 1 Bartlett D. Moore, John M. Slopis, Edward F. Jackson, Neurology	2000	143
Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1–associated, and radiation-associated malignant peripheral nerve sheath tumors Kelsey L. Watson, Ghadah Al Sannaa, Christine M. Kivlin, Journal of neurosurgery Tumor InnervationPathologyNeurofibromatosis Type 1–AssociatedPeripheral NervesNeuromas	2016	142
Clinical spectrum of individuals with pathogenic <i> <b>N</b> F1 </i> missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1 Magdalena Koczkowska, Tom Callens, Yunjia Chen, Human Mutation	2019	130
Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex Mary Kay Koenig, Adelaide A. Hebert, Joan Roberson, Drugs in R&D	2012	128
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex Mary Kay Koenig, Cynthia Bell, Adelaide A. Hebert, JAMA Dermatology	2018	92

Page 1